# Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention

> **NCT06463808** · — · RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Ventricular Remodeling
- Myocardial Infarction, Anterior Wall

## Interventions

- **DRUG:** Recombinant Human Brain Natriuretic Peptide

## Key facts

- **NCT ID:** NCT06463808
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-03
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-02-28
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06463808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06463808, "Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06463808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*